Jersey Shore University Medical Center
Jersey Shore University Medical Center
News Article | May 7, 2017
"It is truly inspiring to see how many community groups held bake sales, car washes and other fundraisers for this cause, and I want to challenge more of them to join our team," said Manning, who pledged to match the first $100,000 in fundraising from local community groups – which they exceeded in just a few short months. Five of the most innovative, creative and successful fundraising campaigns created by kids and community groups were honored, resulting in a check for $250,000 from "Eli's Challenge" to the Tackle Kids Cancer program, which benefitted from the New York Giants support. "We value our relationship with Hackensack University Medical Center and are honored to be part of Tackle Kids Cancer. The work that is done by the Children's Cancer Institute and those who have contributed to Tackle Kids Cancer has served as an inspiration to Eli and all of us," said Allison Stangeby, vice president of Community and Corporate Relations. "We are proud of Eli's work in our community and his selfless support of the Children's Cancer Institute." The event was part of NBC4 Telemundo Health Expo, Presented by Quest Diagnostics, which is held annually at MetLife Stadium welcoming a wide range of healthy lifestyle exhibits, as well as free health tests and screenings. "The Foundation is proud of the partnership we have with the New York Giants and its players," said Jon M. Fitzgerald, president of Hackensack University Medical Center Foundation. "Eli Manning's commitment to Tackle Kids Cancer has extended far beyond what we could have imagined. Not only has he volunteered to be the face of our campaign, but he has made numerous visits with the children, families and health care team at our Children's Cancer Institute. With Eli's Challenge, he has taken his role as champion of this cause to higher level, and we could not have raised more than $4 million for our Tackle Kids Cancer initiative without his support." The Children's Cancer Institute at Hackensack University Medical Center consists of dedicated clinicians and researchers specializing in pediatric cancer. With more than 100 active oncology and transplant clinical trials currently open, it is leading the charge to cure childhood cancer. "While extremely rare, pediatric cancer is the number one cause of death by disease in children in the U.S.," said Stephen Percy, M.D., interim chairman, Department of Pediatrics, Joseph M. Sanzari Children's Hospital. "Every dollar received through the Tackle Kids Cancer campaign will support our most important programs and research." ABOUT HACKENSACK MERIDIAN HEALTH Hackensack Meridian Health is a leading not-for-profit health care organization that is the most comprehensive and truly integrated health care network in New Jersey, offering a complete range of medical services, innovative research and life-enhancing care. Hackensack Meridian Health comprises 13 hospitals, including two academic medical centers, two children's hospitals and nine community hospitals, physician practices, more than 120 ambulatory care centers, surgery centers, home health services, long-term care and assisted living communities, ambulance services, lifesaving air medical transportation, fitness and wellness centers, rehabilitation centers, and urgent care and after-hours centers. Hackensack Meridian Health has 28,000 team members, more than 6,000 physicians and is a distinguished leader in health care philanthropy, committed to the health and well-being of the communities it serves. The Network's notable distinctions include having one of only five major academic medical centers in the nation to receive Healthgrades America's 50 Best Hospitals Award for five or more consecutive years, the number one hospital in New Jersey as ranked by U.S. News and World Report, consistently achieving Magnet® recognition for nursing excellence from the American Nurses Credentialing Center, recipient of the John M. Eisenberg Award for Patient Safety and Quality from The Joint Commission and the National Quality Forum, a six-time recipient of Fortune's "100 Best Companies to Work For," one of the "20 Best Workplaces in Health Care" in the nation, and the number one "Best Place to Work for Women." Hackensack Meridian Health is a member of AllSpire Health Partners, an interstate consortium of leading health systems, to focus on the sharing of best practices in clinical care and achieving efficiencies. The hospitals of Hackensack Meridian Health include: academic medical centers – Hackensack University Medical Center in Hackensack, Jersey Shore University Medical Center in Neptune; children's hospitals – Joseph M. Sanzari Children's Hospital in Hackensack, K. Hovnanian Children's Hospital in Neptune; community hospitals – Ocean Medical Center in Brick, Riverview Medical Center in Red Bank, Mountainside Medical Center in Montclair, Palisades Medical Center in North Bergen, Raritan Bay Medical Center in Perth Amboy, Southern Ocean Medical Center in Manahawkin, Bayshore Medical Center in Holmdel, Raritan Bay Medical Center in Old Bridge, and Pascack Valley Medical Center in Westwood. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/eli-manning-headlines-tackle-kids-cancer-all-stars-event-300452803.html
News Article | December 8, 2016
ALBANY, N.Y.--(BUSINESS WIRE)--In response to the critical need for better healthcare environments for children, EYP Inc., national leader in sustainability and comprehensive high-performance design, announced its intent to acquire Atlanta-based Stanley Beaman & Sears, an award-winning architecture and interior design firm and pioneer in the design of children’s hospitals. This union brings an additional specialization to EYP’s healthcare practice and specifically addresses the global need for high-quality, innovative pediatric care facilities. Both parties have signed a letter of intent with anticipation of closing by Dec. 31, 2016. Stanley Beaman & Sears was the first to integrate technology for education and entertainment into children’s hospitals to enhance young patients’ journey to health and wellness. Sharing EYP’s commitment to expertise driven design, Stanley Beaman & Sears has worked on pediatric care facilities for renowned clients, including St. Jude Children’s Research Hospital, Nemours Children’s Hospital, Children’s Healthcare of Atlanta, University of Chicago Comer Children’s Hospital, Children’s Hospital of New Orleans, and University of Virginia Medical Center, among others. Additionally, the pediatric firm is involved with a range of philanthropic work in support of child health in Africa. The addition of Stanley Beaman & Sears continues to grow EYP’s international healthcare presence. In 2014, EYP acquired WHR Architects to lead its healthcare practice, which is consistently ranked No.1 in healthcare renovation by Health Facilities Management Magazine. The group has seen continuous success and recognition for their deep expertise in evidence-based design, patient-centered care and behavioral healthcare in both new and renovation projects, such as Stamford Hospital, Jersey Shore University Medical Center, Fulton State Psychiatric Hospital, and Denmark’s Bispebjerg Somatic Hospital. As the premier pediatric design firm practice in the U.S., Stanley Beaman & Sears complements the expertise of the group and expands EYP’s team of experts in healthcare design, client-focused care and biomedical research. The combined resources of WHR Architects and Stanley Beaman & Sears now places EYP among the largest healthcare design practices in the country. Stanley Beaman & Sears also brings added expertise in experiential graphic design and interior design to EYP, complementing EYP’s offerings for the government, higher education, healthcare, science & technology and corporate industries. Stanley Beaman & Sears has provided these areas of expertise for such clients as Georgia Institute of Technology, University of Virginia, Children’s Healthcare of Atlanta, Children’s Hospital of Philadelphia, the Georgia Museum of Art and the new Mercedes Benz Stadium in Atlanta. “We design for clients who recognize that the fulfillment of their mission is directly linked to the performance of their facilities. For over 40 years, we have helped those clients—institutions of higher education, federal agencies, corporations and healthcare providers—advance their vision and goals by providing environments that are informed by deep, relevant knowledge,” said Tom Birdsey, AIA, President and CEO of EYP. “EYP and Stanley Beaman & Sears are united by passion and purpose, fueled by innovation, and focused on furthering our clients’ missions. Together with Stanley Beaman & Sears, we will continue to advance new methods of delivery that respond to the ever-changing needs of pediatric facilities nationwide. Expertise-driven design is our mission—it’s how we help our clients realize their vision.” “It’s hard to imagine a better fit for our culture than EYP,” said Kimberly Stanley, AIA, principal of Stanley Beaman & Sears, “and the benefits to our clients are outstanding. Both firms see design as a collaborative journey of discovery with our clients. We’re excited about having in-house engineers and energy specialists on our project teams as well as being able to offer EYP clients new expertise and services.” ABOUT STANLEY BEAMAN & SEARS: Stanley Beaman & Sears, based in Atlanta, Georgia, is an award-winning architecture, interiors and graphic design firm with a focus on healthcare, higher education and the arts. The firm has designed projects for notable universities and academic medical centers nationwide, and is a national leader in the design of healthcare facilities for children. For more information about Stanley Beaman & Sears Architects, visit www.stanleybeamansears.com. ABOUT EYP: EYP is a renowned global provider of high-performance building design, research, and consulting services for higher education, government, healthcare, and corporate clients. EYP is the only firm to have twice been ranked #1 for Energy & Sustainability by Architect Magazine. More than 650 professionals in architecture, engineering, energy, and interior design collaborate across 16 offices in the U.S. and Europe to deliver expertise-driven design. For more information, visit www.eypae.com.
Kountz D.S.,Jersey Shore University Medical Center
Postgraduate Medicine | Year: 2017
Diabetes, hypertension, and severe kidney disease are all disproportionately prevalent in African-Americans. Clinical trials data from type 2 diabetes (T2D) patients have demonstrated that sodium-glucose cotransporter 2 (SGLT2) inhibitors have a positive effect on cardiovascular risk factors–such as improved blood glucose control, reduced body weight, and reduced blood pressure–and also support a possible renal-protective role for SGLT2 inhibitors. The EMPA-REG OUTCOME® trial revealed that empagliflozin was associated with reduced adverse cardiovascular and renal outcomes. Thus, SGLT2 inhibitors could potentially provide clinicians with a treatment option that addresses multiple pathophysiologic aspects of the cardiometabolic disease processes that may affect end-organ function in African-American patients with T2D and hypertension. This review examines some of the clinical issues associated with this patient group and the role that SGLT2 inhibitors may provide in their treatment. © 2017 Informa UK Limited, trading as Taylor & Francis Group.
Walker L.R.,Jersey Shore University Medical Center
Journal of pregnancy | Year: 2011
Outside of Wilson's Disease, abnormal copper metabolism is a rare condition. In pregnancy, excess copper levels can be associated with intrauterine growth restriction, preeclampsia and neurological disease. A 32 year old Gravida 4 para 2012 with an obstetrical history complicated by elevated copper levels presented for routine prenatal care. Her children had elevated copper levels at birth, with her firstborn child being diagnosed with autism and suffering three myocardial infarctions and being treated for elevated copper levels. During her prior pregnancies, she declined treatment for her elevated copper levels. During this pregnancy, she had declined chelation therapy and instead choose zinc therapy. She delivered a healthy infant with normal copper levels. Alterations in copper metabolism are rare, the consequences in pregnancy can be devastating. While isolated elevations of copper in pregnancy is exceedingly rare, it is treated the same as Wilson's disease. The goal is to prevent fetal growth restricting and neurological sequelae in the newborn and preeclampsia in the mother. Counseling, along with treatment options and timely delivery can greatly improve neonatal and maternal outcome.
Carson M.P.,Rutgers Robert Wood Johnson Medical School |
Carson M.P.,Jersey Shore University Medical Center
Seminars in Perinatology | Year: 2015
Women with preeclampsia, gestational diabetes, and obesity during pregnancy are at risk for medical complications later in life. Therefore, practitioners should identify those who can benefit from early diagnosis and interventions. Metabolic syndrome is a cluster of risk factors including hypertension, elevated triglycerides, low high-density lipoprotein cholesterol, glucose intolerance, and obesity, which also identifies those at risk for cardiovascular disease. Taking the time to classify women with the metabolic syndrome does not necessarily offer risk stratification superior to that offered by identifying the individual components. This article will offer conclusions regarding the need for busy obstetrician/gynecologists to make this classification. © 2015 Elsevier Inc.
Kountz D.S.,Jersey Shore University Medical Center
Postgraduate medicine | Year: 2013
Black individuals are at high risk for hypertension and increased morbidity from cardiovascular and renal disease, in particular. Increased understanding of racial disparities in hypertension, in terms of risk factors, patient/physician behaviors, and treatment outcomes, is key to improving racially oriented care in black patients. Recent data suggest that black patients progress more rapidly from prehypertension to hypertension, highlighting the need for early and prompt intervention. Unfortunately, adherence to and persistence with antihypertensive therapy are generally poor in black patients and are compounded by the increased need for multidrug therapy in this patient population. Treatment strategies currently under investigation are focusing on methods to improve self-care behaviors and medication adherence. Because this is a constantly and rapidly evolving field of study, this article provides an update of recent findings that should be of relevance and interest to practicing clinicians.
Oyelese Y.,Jersey Shore University Medical Center
Clinical Obstetrics and Gynecology | Year: 2012
The placenta and umbilical cord are crucial to the survival and well-being of the fetus. In fact, disorders of either of these may lead to fetal death or severe morbidity. Yet, they are often not accorded appropriate attention in the prenatal sonographic examination. Similarly, the amniotic fluid often reflects the state of fetal health. Frequently, disorders of the placenta, umbilical cord, and amniotic fluid are picked up during routine ultrasound examination. Without ultrasound, these problems would not be detected and might jeopardize the pregnancy. Detection allows interventions that may improve perinatal and maternal outcomes. However, not infrequently, controversial findings, of uncertain significance, demonstrated on routine sonography lead to anxiety and worry. The goal of this chapter is to address the normal appearances of the placenta, cord, and fluid and to describe several of the more common conditions affecting these structures that the clinician may have to deal within pregnancy. © 2012, Lippincott Williams & Wilkins.
Kountz D.,Jersey Shore University Medical Center
Journal of the National Medical Association | Year: 2012
It is well documented that African American populations are disproportionately affected by type 2 diabetes mellitus compared with their white counterparts. They have a higher prevalence of diabetes, a higher rate of diabetes-related complications, greater disability from these complications, and poorer control and quality of care. In order to improve diabetes care and outcomes in African Americans (and indeed all patients with diabetes), a multifactorial approach is needed to target all risk factors - not solely hyperglycemia - simultaneously. Culturally appropriate initiatives to improve lifestyle behaviors are a first step in management. Community-based programs, including those mediated through church groups, have reported varying degrees of success in effecting such beneficial lifestyle changes. If these measures fail to achieve desirable levels of blood glucose, blood pressure, and serum lipids, pharmacologic therapy is indicated. However, few evidence-based recommendations regarding the use of some drugs in African Americans currently exist due to their underrepresentation in randomized controlled clinical trials. Other essential components of diabetes care include regular screening for diabetic nephropathy and neuropathy, and eye and foot examinations, with prompt referral to specialists when important clinical changes are detected.
Parks K.R.,Jersey Shore University Medical Center |
Kuo Y.-H.,Jersey Shore University Medical Center |
Davis J.M.,Jersey Shore University Medical Center |
O'Brien B.,Jersey Shore University Medical Center |
Hagopian E.J.,Jersey Shore University Medical Center
HPB | Year: 2014
Background: Laparoscopic liver resection is growing in popularity, but the long-term outcome of patients undergoing laparoscopic liver resection for malignancy has not been established. This paper is a meta-analysis and compares the long-term survival of patients undergoing laparoscopic (LHep) versus open (OHep) liver resection for the treatment of malignant liver tumours. Methods: A PubMed database search identified comparative human studies analysing LHep versus OHep for malignant tumours. Clinical and survival parameters were extracted. The search was last conducted on 18 March 2012. Results: In total, 1002 patients in 15 studies were included (446 LHep and 556 OHep). A meta-analysis of overall survival showed no difference [1-year: odds ratio (OR) 0.71, 95% confidence interval (CI) 0.42 to 1.20, P = 0.202; 3-years: OR 0.76, 95% CI 0.56 to 1.03, P = 0.076; 5-years: OR 0.8, 95% CI 0.59 to 1.10, P = 0.173]. Subset analyses of hepatocellular carcinoma (HCC) and colorectal metastases (CRM) were performed. There was no difference in the 1-, 3-, and 5-year survival for HCC or in the 1-year survival for CRM, however, a survival advantage was found for CRM at 3 years (LHep 80% versus OHep 67.4%, P = 0.036). Conclusions: Laparoscopic surgery should be considered an acceptable alternative for the treatment of malignant liver tumours. © 2013 International Hepato-Pancreato-Biliary Association.
Zheng M.,Jersey Shore University Medical Center
Surgical Oncology Clinics of North America | Year: 2016
Advancement in the understanding of lung tumor biology enables continued refinement of lung cancer classification, reflected in the recently introduced 2015 World Health Organization classification of lung cancer. In small biopsy or cytology specimens, special emphasis is placed on separating adenocarcinomas from the other lung cancers to effectively select tumors for targeted molecular testing. In resection specimens, adenocarcinomas are further classified based on architectural pattern to delineate tissue types of prognostic significance. Neuroendocrine tumors are divided into typical carcinoid, atypical carcinoid, small cell carcinoma, and large cell neuroendocrine carcinoma based on a combination of features, especially tumor cell proliferation rate. © 2016 Elsevier Inc.